Overview
AIDX market data
Price History
AIDX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- — Diluted earnings per share over the trailing twelve months.
- Beta
- 2.51 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.49 – $50.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap —.
Company news
BioLabs Announces Standstill Agreement With Streeterville Capital Regarding Outstanding Series E Convertible Preferred Stock, Effective July 16Benzinga · Jul 23, 2026, 12:41 PM
8-K filing — 20/20 Biolabs, Inc. (AIDX)SEC EDGAR · Jul 22, 2026, 8:45 PM
Why Super Micro Computer Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 22, 2026, 8:47 AM
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each MonthGlobenewswire Inc · Jun 22, 2026, 9:15 PM
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response EffortsBenzinga · Jun 5, 2026, 6:30 PM
20/20 Biolabs' OneTest Multi-Cancer Early Detection Blood Test Selected As Part Of Firefighter Cancer Screening Initiative For State Of Vermont In Partnership With National Diagnostic ServicesBenzinga · May 27, 2026, 12:36 PM
20/20 Biolabs Q1 EPS $(0.28) Misses $(0.10) Estimate, Sales $353.375K Miss $779.000K EstimateBenzinga · May 20, 2026, 8:25 PM